2019
DOI: 10.1016/j.tiv.2018.10.020
|View full text |Cite
|
Sign up to set email alerts
|

Comparative cytotoxicity of plant protection products and their active ingredients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 24 publications
0
7
0
Order By: Relevance
“…Co-formulants perform specific functions in the formulation, such as solvents, surfactants, diluents, thickeners, dispersing agents, binding agents, stabilizing agents, wetting agents, antifoaming agents, preservatives or antifreeze agents. [8][9][10] In the context of PPP toxicity, Regulation (EU) 284/2013 11 mainly evaluates acute effects through tests for acute toxicity, irritation and skin sensitization. However, as generally active substances assumed to dominate toxicity, they are analyzed thoroughly for acute, chronic and subchronic effects in short-and long-term in vivo studies.…”
Section: Introductionmentioning
confidence: 99%
“…Co-formulants perform specific functions in the formulation, such as solvents, surfactants, diluents, thickeners, dispersing agents, binding agents, stabilizing agents, wetting agents, antifoaming agents, preservatives or antifreeze agents. [8][9][10] In the context of PPP toxicity, Regulation (EU) 284/2013 11 mainly evaluates acute effects through tests for acute toxicity, irritation and skin sensitization. However, as generally active substances assumed to dominate toxicity, they are analyzed thoroughly for acute, chronic and subchronic effects in short-and long-term in vivo studies.…”
Section: Introductionmentioning
confidence: 99%
“…However, this method produces a high number of falsenegative predictions compared with in vivo derived classification for PPPs although intended to provide worst-case estimation. 5,[59][60][61][62] For example, Kurth et al assessed all authorised PPPs on the German market that were classified for the specific endpoints. 61 They concluded that false-negative predictions using the CLP calculation method were especially high at ∼ 40% for acute oral and inhalation toxicity.…”
Section: The Clp Calculation Methodsmentioning
confidence: 99%
“…For this purpose, we propose to investigate the applicability of liver cell cytotoxicity testing and the zebrafish early-life stage test. 5,6,32 The test systems were selected based on regulatory acceptance, the relevance of target sites, and sensitivity. On the one hand, they allow for the investigation of the kinetic influence of co-formulants on AS bioavailability.…”
Section: Tiered Toxicity Testingmentioning
confidence: 99%
See 1 more Smart Citation
“…Although co-formulants are by definition non-active, they contribute to toxicodynamic or toxicokinetic mixture effects, potentially resulting in the altered toxicity of the PPP. In recent years several articles were published comparing active substances and PPPs, showing that the products may exhibit increased toxic effects (Adler-Flindt and Martin 2019;Hernandez et al 2013;Zahn et al 2018). Furthermore, Regulation (EU) 1107/2009 requires that "interaction between the active substance, safeners, synergists and coformulants shall be taken into account" in the evaluation and authorisation of PPPs (EC 2009).…”
Section: Introductionmentioning
confidence: 99%